How a 1956 Antitrust Decree Forced Bell Labs to Give Away the Future

In 1956, AT&T settled a seven-year antitrust fight by agreeing to license all 7,820 of its unexpired patents royalty-free to any American firm, and to license future patents at reasonable rates. The same settlement barred Bell from any business outside telecom — a restriction that mattered because roughly 69% of its patents had nothing to do with phones, spanning chemistry, semiconductors, optics, and more. Regulators framed it as a win, though critics called it a slap on the wrist. In practice, it dumped about 1.3% of all live U.S. patents into the public market overnight, generating close to $6 billion in follow-on value, much of it captured by startups. That cascade ran straight through Shockley and Fairchild into Intel; Gordon Moore credited Bell’s liberal licensing with launching Silicon Valley itself.

The essay’s sharper argument is structural: Bell Labs worked because AT&T’s regulated-monopoly economics made research uniquely rewarding. With returns fixed at roughly 7% of invested capital and R&D treated as a recoverable, ratepayer-subsidized cost that also expanded the rate base, every research dollar both paid for itself and grew guaranteed profit. The author likens this to a rice paddy — an engineered environment that fertilizes itself for generations — while conceding the real costs: over-investment, no price discipline, and an incentive to hoard inventions behind the monopoly wall.

The piece then pivots to today’s frontier science, now built on model weights, GPUs, and token spend inside a handful of AI labs. It notes that AI is already cracking previously intractable problems in protein folding, mathematics, materials, and drug discovery — but asks where that fertile soil comes from. The answer, it argues, is no secret: labs like OpenAI and Anthropic train primarily on publicly available information, setting up the essay’s central tension between publicly generated genius and its private capture.